Co-Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Co-Diagnostics, Inc. (CODX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $4.74 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2022-03-24
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $2.80.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $4.74.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $1.24, a 22.01% decline from fiscal 2017.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $1.59, a 1345.45% increase from fiscal 2016.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $0.11.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $4.74 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $4.75 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | $4.70 10-Q/A · filed 2020-11-03 | ||||
| 2020-03-31 | $2.80 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $0.52 10-Q/A · filed 2020-11-03 | ||||
| 2019-09-30 | $0.51 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $0.52 10-Q · filed 2019-08-14 | ||||
| 2018-12-31 | $1.24 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $1.93 10-Q · filed 2018-11-14 | ||||
| 2017-12-31 | $1.59 10-K · filed 2019-04-01 | $1.74 10-K · filed 2018-03-28 | |||
| 2017-09-30 | $1.59 10-Q · filed 2018-11-14 | ||||
| 2016-12-31 | $0.11 10-K · filed 2018-03-28 | ||||
| 2016-06-30 | $0.44 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |